Effects of the lesion size on clinically significant prostate cancer detection rates in PI-RADS category 3-5 lesions
Authors:
- 16 February 2024
- journal article
- research article
- Published by Elsevier in Actas Urológicas Españolas (English Edition)
- Vol. 48 (7) , 526-531
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysisEuropean Urology Oncology, 2021
- PI-RADS 3 lesions: Does the association of the lesion volume with the prostate-specific antigen density matter in the diagnosis of clinically significant prostate cancer?Urologic Oncology: Seminars and Original Investigations, 2021
- Papel de la resonancia magnética multiparamétrica en la selección y el seguimiento de pacientes en vigilancia activa por cáncer de próstata. Revisión del grupo de Uro-Tecnología (ESUT) de la EAUActas Urológicas Españolas, 2021
- Risk Stratification of Prostate Cancer According to PI-RADS® Version 2 Categories: Meta-Analysis for Prospective StudiesJournal of Urology, 2020
- Prostate MRI evolution in clinical practice: Audit of tumour detection and staging versus prostatectomy with staged introduction of multiparametric MRI and Prostate Imaging Reporting and Data System v2 reportingJournal of Medical Imaging and Radiation Oncology, 2019
- Epidemiology of Prostate CancerWorld Journal of Oncology, 2019
- Re: Risk Stratification of Equivocal Lesions on Multiparametric Magnetic Resonance Imaging of the ProstateJournal of Urology, 2018
- Evaluating the size criterion for PI-RADSv2 category 5 upgrade: is 15 mm the best threshold?Abdominal Radiology, 2018
- The Contemporary Concept of Significant Versus Insignificant Prostate CancerEuropean Urology, 2011
- Pathologic and Clinical Findings to Predict Tumor Extent of Nonpalpable (Stage T1 c) Prostate CancerJAMA, 1994